Clinical trial · Interventional
Medically Tailored Meals for Kids
Feasibility of Medically Tailored Meals for Pediatric Populations at Risk for Disparities in Serious Illness Outcomes Due to Inequities in Social Drivers of Health (MTM-Kids)
NCT06814795CI-TRIAL-00124103MTM-Kidsactive not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this project is to learn whether an intervention that provides households with home-delivered healthy, frozen meals tailored to illness related conditions for 12 weeks during a child's treatment for serious illness is feasible and acceptable to the child and parent mainly responsible for the child's care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pediatric Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Medically tailored meals | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Medically-tailored meals for children being treated for cancer with chemotherapy
- description
- The intervention will be 12-weeks induration, with weekly "doses" (meal deliveries) of up to 10 healthy, frozen meals per week for household use as needed, plus selected condiments for personalization.
- interventionNames
- Other: Medically tailored meals
Primary outcomes (2)
- measure
- Parent-reported feasibility, acceptability, appropriateness and accessibility of MTM-Kids
- timeFrame
- Baseline and 12 weeks
- description
- Each domain will be measured by 4-items developed by others and adapted for this study. Parents will be asked to read each item and indicate their response using 5-point scales anchored by 1=completely disagree and 5=completely aDomain scores will be calculated by summing item responses and dividing the sum by 4. Domain score range is 1-higher scores indicating better MTM program feasibility, acceptability, appropriateness and accessibility.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 12 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: Eligible children (n=15) will: * be under the care of The University of North Carolina at Chapel Hill School of Medicine, Department of Pediatrics, Division of Pediatric Hematology/Oncology * have completed at least one cycle of cancer chemotherapy that included an agent known to cause alterations in taste, * expect to undergo at least two more cycles, * be aged 12-17.9 years * communicate in English or Spanish. Eligible adults (n=15) will: * be the primary parental caregiver of a study-eligible child, * be aged 18 years or older * communicate in English or Spanish. Exclusion Criteria: * none if inclusion criteria are met
References
Publications (35)
- BACKGROUNDColeman-Jensen A, Rabbitt MP, Gregory CA, Singh A. Household Food Security in the United States inU.S. Department of Agriculture Economic Research Service. Washington, D. C. 2022.
- BACKGROUNDMozaffarian D. Measuring and addressing nutritional secutiry to achieve health and health equity HeAffairs Health Policy Brief. March 30, 2023. https://doi.org/10.1377/hpb2023216.92558
- BACKGROUNDCOUNCIL ON COMMUNITY PEDIATRICS. Poverty and Child Health in the United States. Pediatrics. 2016 Apr;137(4):e20160339. doi: 10.1542/peds.2016-0339. Epub 2016 Mar 9. PMID 26962238
- BACKGROUNDZenk SN, Tabak LA, Perez-Stable EJ. Research Opportunities to Address Nutrition Insecurity and Disparities. JAMA. 2022 May 24;327(20):1953-1954. doi: 10.1001/jama.2022.7159. No abstract available. PMID 35486390
- BACKGROUNDKelley AS. Defining "serious illness". J Palliat Med. 2014 Sep;17(9):985. doi: 10.1089/jpm.2014.0164. Epub 2014 Aug 12. No abstract available. PMID 25115302
- BACKGROUNDBona K, Blonquist TM, Neuberg DS, Silverman LB, Wolfe J. Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000-2010). Pediatr Blood Cancer. 2016 Jun;63(6):1012-8. doi: 10.1002/pbc.25928. Epub 2016 Feb 23. PMID 26913850
- BACKGROUNDWadhwa A, Chen Y, Hageman L, Hoppmann A, Angiolillo A, Dickens DS, Neglia JP, Ravindranath Y, Ritchey AK, Termuhlen A, Wong FL, Landier W, Bhatia S. Poverty and relapse risk in children with acute lymphoblastic leukemia: a Children's Oncology Group study AALL03N1 report. Blood. 2023 Jul 20;142(3):221-229. doi: 10.1182/blood.2023019631. PMID 37070673
- BACKGROUNDBona K, Li Y, Winestone LE, Getz KD, Huang YS, Fisher BT, Desai AV, Richardson T, Hall M, Naranjo A, Henderson TO, Aplenc R, Bagatell R. Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma. J Natl Cancer Inst. 2021 Mar 1;113(3):282-291. doi: 10.1093/jnci/djaa107.